Introduction
Renal involvement is increasingly being recognized as a major manifestation of Laurence-Moon-Biedl syndrome (LMBS).1 -Early autopsy series revealed that 90% of patients with LMBS have some form of renal abnormality including cystic changes, hydroureter, hydronephrosis, pyelonephritis, nephrosclerosis and glomerulonephritis. ' 3 In addition, renal failure was considered the cause of death in up to 30% of these patients. 2'5 A limited number of reports on the renal biopsy findings from patients suffering from LMBS have demonstrated characteristic glomerular and tubulointerstitial changes.5 '7-9 We wish to report a case of LMBS presenting with nephrotic change proteinuria which responded to steroid therapy. In (Figure 1 ). Footprocess fusion was extensive (Figure 1 ). Diffuse thickening of the lamina densa of the glomerular basement membrane (GBM), as in diabetic glomerulosclerosis, was absent. However, segmental GBM thickening was present along with segments of widened lamina rara interna. Occasional granular inclusion bodies were found in the widened lamina rara interna ( Figure 1 ).
Steroid treatment was started at a dose of 60mg daily after further documentation of nephrotic proteinuria. This dose was maintained for 5 weeks after which steroid was gradually tailed off over the c.
-_ -group.bmj.com on October 29, 2017 -Published by http://pmj.bmj.com/ Downloaded from next 6 weeks. Proteinuria decreased from the pretreatment level of 9 g/day to 0.74 g/day by 2 months after steroid therapy. Serum creatinine increased slightly to 0.290 mmol/l at 1 month after steroid treatment but stabilized at 0.220 mmol/l. Serum albumin and cholesterol remained within the normal limits while the blood sugar level was maintained in the upper limit of normal with metformin 250mg twice a day. At the last followup 16 months after steroid therapy, the serum creatinine was 0.200mmol/l, 24 hour urine protein was 0.4g/day and his blood sugar level remained within the normal range after cessation of metformin.
Discussion
The clinicopathological features of the renal lesion in the present case and in other published cases, in which detailed information of the renal biopsy findings are available, are shown in Table I . Glomerular lesions which have been described include mesangial proliferation and sclerosis, increase in mesangial matrix and ultrastructural GBM abnormalities. The basis of these glomerular abnormalities in LMBS is unclear at present. The hereditary nature of LMBS and the GBM changes would suggest a metabolic defect affecting the GBM. On the other hand, the glomerular abnormalities may be secondary to pelvicalyceal abnormalities which are frequently demonstrated in patients with LMBS.
Nephrotic range proteinuria is unique to our present case. Whether the nephrotic proteinuria is part of LMBS or is coincidental is debatable. Although ultrastructural GBM abnormalities were found in our patient, they are unlikely to be the cause of nephrotic proteinuria as similar abnormalities were found in non-nephrotic patients with LMBS (Table I ). However, they may explain the residual proteinuria which was still present in our patient after steroid-induced remission. As the patient was also found to have diabetes mellitus at the time proteinuria was discovered, the suggestion may be made that the nephrotic proteinuria is secondary to diabetes mellitus. However, the very mild nature of his diabetes together with the lack of histological evidence of diabetic nephropathy strongly argues against the latter being the cause of proteinuria in this patient. The presence of abnormal serum liver enzymes and hepatitis B antigenaemia may also suggest that the proteinuria is related to hepatitis B infection but the histological pattern of glomerular involvement in this patient is not typical of that in hepatitis B-associated glomerulonephropathy which are usually membranous or mesangiocapillary in type. 12 The nephrotic range proteinuria may be secondary to minimal change nephropathy, or, in view of the finding that 1 of 11 glomeruli is sclerotic, to focal global sclerosis. The presence of a childhood history of nephritis, the demonstration of extensive epithelial foot-process fusion in the renal biopsy and steroid responsiveness are consistent with both diagnoses. However, the histological findings in this patient do not satisfy Habib's criteria for the diagnosis of focal global sclerosis in idiopathic nephrotic syndrome.'3 The latter require the presence of >15-20% of glomeruli to be affected by global sclerosis together with tubulointerstitial scarring in a renal biopsy obtained from a patient in whom the diagnosis of minimal change nephropathy would otherwise be made. Furthermore, occasional sclerotic glomeruli have been found in the renal biopsies from some non-nephrotic patients with LMBS (Table I ) and these changes may be secondary to accelerated glomerular drop out consequent upon GBM or pelvicalyceal abnormalities.
Having considered the various possibilities, we concluded that this patient most likely has minimal change nephropathy superimposed on the renal lesion of LMBS. Whether patients with LMBS are more prone to develop minimal change nephropathy or that the two conditions are merely found coincidentally cannot be determined in the present report. However, the occurrence of minimal change nephropathy in a patient with LMBS highlights the importance of careful clinical, laboratory and renal biopsy assessment of patients with LMBS presenting with nephrotic range proteinuria.
